Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer
- Resource Type
- Article
- Source
- In
Value in Health January 2018 21(1):9-17 - Subject
- Language
- ISSN
- 1098-3015